SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 55.11-2.6%Nov 7 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: IRWIN JAMES FRANKEL who wrote (5738)2/24/2002 6:26:52 PM
From: tom pope  Read Replies (1) of 52153
 
they are indeed toxic, indeed worse - note the put option:

PEMBROKE, Bermuda, February 7, 2001 -- Tyco International Ltd. (NYSE: TYC; LSE: TYI; BSX: TYC) today announced that it has agreed to sell $3,035,000,000 principal amount at maturity of zero-coupon convertible senior debentures due 2021, to be issued by Tyco International Group S.A. (“Tyco S.A.”) and guaranteed by Tyco. The debentures are being offered only to qualified institutional buyers at an initial offering price of $741.65 per $1,000 principal amount at maturity, with gross proceeds of approximately $2,250,907,750. The initial purchaser will also have a 30 day option to purchase up to an additional $455,250,000 principal amount at maturity of debentures to cover over-allotments which would give Tyco S.A. an additional $337,636,162 in gross proceeds. Each $1,000 principal amount at maturity debenture will be convertible into 8.6916 Tyco common shares if the closing price of Tyco's common shares on the New York Stock Exchange exceeds specified levels or in the event Tyco takes certain corporate actions, such as declaration of an extraordinary dividend. The debentures will not be redeemable by Tyco S.A. prior to February 12, 2009 but Tyco S.A. may be required to repurchase debentures at the accreted value thereof, at the option of the holders, on February 12, 2003, 2005, 2007, 2009, or 2016. Tyco S.A. may choose to pay the purchase price for the February 12, 2003 repurchase in cash, Tyco common shares or a combination of cash and Tyco common shares. All other repurchases must be paid in cash. Tyco S.A. will use the proceeds of the offering to refinance commercial paper

And I thought toxics were the speciality of small, desperate and undercapitalized companies.

The following is also interesting, emphasizing the put lurking in many of these issues:

thestreet.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext